Co-Authors
This is a "connection" page, showing publications co-authored by FARHAD RAVANDI-KASHANI and WEIGUO ZHANG.
Connection Strength
0.235
-
Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies. Clin Cancer Res. 2014 May 01; 20(9):2363-74.
Score: 0.124
-
Potential role of sorafenib in the treatment of acute myeloid leukemia. Leuk Lymphoma. 2008 Dec; 49(12):2246-55.
Score: 0.086
-
Phase I study of sorafenib in patients with refractory or relapsed acute leukemias. Haematologica. 2011 Jan; 96(1):62-8.
Score: 0.024